Cas:1253526-90-7 8-Bromo-1,2,3,4-tetrahydropyrido[3,4-b]pyrazine manufacturer & supplier

Chemical Name:8-Bromo-1,2,3,4-tetrahydropyrido[3,4-b]pyrazine

CAS.NO:1253526-90-7

Synonyms:8-Bromo-1,2,3,4-tetrahydropyrido[3,4-b]pyrazine

Molecular Formula:C₇H₈BrN₃

Molecular Weight:214.06300

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:36.95000

Exact Mass:212.99000

LogP:1.95750

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 8-Bromo-1,2,3,4-tetrahydropyrido[3,4-b]pyrazine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,8-Bromo-1,2,3,4-tetrahydropyrido[3,4-b]pyrazine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,8-Bromo-1,2,3,4-tetrahydropyrido[3,4-b]pyrazine Use and application,8-Bromo-1,2,3,4-tetrahydropyrido[3,4-b]pyrazine technical grade,usp/ep/jp grade.

Related News: RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO 3-Isothiazolecarboxylic acid, 4,5-dichloro-, pentadecyl ester manufacturers Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients. (5S,6R)-6-(tert-Butyl-dimethyl-silanyl)-2,2-dimethyl-dodecane-3,5-diol suppliers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. α-D-galactopyranosyl β-D-fructofuranosyl-(2-6)-β-D-fructofuranoside vendor & factory RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO,Our COVID-19 vaccine, Vaxzevria, undergoes extremely robust safety and quality testing prior to becoming available for patients.